Commercial Collaboration & Patents
The Marshall Team is committed to appropriately commercializing the ground-breaking research conducted at the Research Analytical Biochemistry Lab (RABL) to the benefit of Canadians and the world.
is a private life sciences company based in Toronto. YYZ invents and develops diagnostic and therapeutic technology for use in modern pharmaceuticals, with breakthroughs in the discovery and ultra-sensitive quantification of biomolecules. YYZ is a proud supporter and commercialization partner of the Marshall Team in the Research Analytical Biochemistry Lab (RABL) at ³Ô¹ÏÖ±²¥.
Previous Collaborations
The Marshall Team is pleased to have worked together with the following organizations on previous research projects:
- Imperial Chemical Industries
- Astra Zeneca
- Heart and Stroke Foundation
- Ontario Cancer Biomarker Network
- Canadian Foundation for Innovation
- Natural Science and Engineering Research Council (NSERC)
- Fonds National de la Recherche Luxembourg
- Carl Zeiss AG
- SCIEX
Patents
Having secured 40+ patents over the course of his career, Dr. John G. Marshall has built a reputation for discovery & innovation. The Marshall Team recognizes the importance of securing intellectual property around new technologies, and educating the next generation of students on this process.
Recent & noteworthy patents:
- US PATENT# 9,964,538 May 8, 2018, Methods and compositions for enzyme linked immuno and hybridization mass spectrometric assay; Marshall; John G. (Toronto, CA), Florentinus; Angelica Kirsten (Richmond Hill, CA) Assignee: YYZ PHARMATECH